SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-22-021687
Filing Date
2022-09-01
Accepted
2022-09-01 16:48:03
Documents
13
Period of Report
2022-08-31
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K govx20220831_8k.htm   iXBRL 8-K 37301
  Complete submission text file 0001437749-22-021687.txt   188791

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA govx-20220831.xsd EX-101.SCH 3995
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE govx-20220831_def.xml EX-101.DEF 13833
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE govx-20220831_lab.xml EX-101.LAB 18092
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE govx-20220831_pre.xml EX-101.PRE 13855
7 EXTRACTED XBRL INSTANCE DOCUMENT govx20220831_8k_htm.xml XML 4234
Mailing Address 1900 LAKE PARK DRIVE SUITE 380 SMYRNA GA 30080
Business Address 1900 LAKE PARK DRIVE SUITE 380 SMYRNA GA 30080 678-384-7220
GeoVax Labs, Inc. (Filer) CIK: 0000832489 (see all company filings)

IRS No.: 870455038 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39563 | Film No.: 221221471
SIC: 2834 Pharmaceutical Preparations